Table 1 Candidate potentially pathogenic (PP) SVs identified in 170 PCa patients

From: Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men

Genes

Gene impact type1

1stChr

pos1

2ndChr

pos2

SV type

ClinVar / dbVar concordance

MAF African (this study)

MAF African (control)2

MAF European (this study)

MAF African (dbVar)3

MAF European (dbVar)3

Potentially Pathogenic SV (PP-SV)

 SLC3A1

IED

chr2

44281377

chr2

44281612

DUP

L-pathogenic

0.01 4

0

0

0.0075

1.3e-04

 OCA2

pLoF

chr15

28017719

chr15

28020677

DEL

L-pathogenic

0.004

0.02

0

0.0015

0.001

 PIGN

pLoF

chr18

62152637

chr18

62157701

DEL

Pathogenic

0.004

0

0

0.0013

1.3e-04

 SLC7A2

pLoF

chr8

17418976

chr8

17544122

DEL

In dbVar

0.009

0

0

0.003

0

 DNAJC15

pLoF

chr13

43078470

chr13

43079390

DEL

In dbVar

0

0

0.009

0

1.0e-04

 BCL2L11

pLoF

chr2

111122626

chr2

111125901

DEL

This study

0.005

0

0

NA

NA

 BARD1

pLoF

chr2

214768022

chr2

214772899

DEL

This study

0.005

0

0

NA

NA

 COL4A2/ COL4A1

CG

chr13

110294204

chr13

110633815

DUP

In dbVar

0.005

0

0

1.3e-04

6.3e-06

 SLC2A5

IED

chr1

9045605

chr1

9049441

DUP

In dbVar

0

0

0.009

7.3e-04

0.002

 FOXP1

pLoF

chr3

71097066

chr3

74525618

INV

This study

0.009

0

0

NA

NA

 WASF1

pLoF

chr6

108167886

chr6

110172775

INV

In dbVar

0.004

0

0

9.6e-05

0

 MLH1

pLoF

chr3

37000362

chr3

39352689

INV

In dbVar

0.004

0

0

4e-04

6.4e-06

 RB1

pLoF

chr13

48466588

chr13

48473911

INV

In dbVar

0.004

0

0

1.8e-04

1.3e-05

 CTNNA1

pLoF

chr5

138903881

chr19

21614900

TRA

This study

0

0

0.009

NA

NA

 AK8-DST

pLoF

chr9

132876361

chr6

56896165

TRA

This study

0

0

0.009

NA

NA

PP-SV candidates classified as ‘cautionary’

 LTBP1/BIRC6

CG

chr2

32403832

chr2

33107415

DUP

In dbVar

0

0

0.009

1.0e-04

0.0018

 PHC3-PRKACA

pLoF

chr3

170090742

chr19

14110142

TRA

This study

0.004

0

0

NA

NA

 KCTD3-DST

pLoF

chr1

215567414

chr6

56652607

TRA

This study

0.009

0

0

NA

NA

 PKHD1

pLoF

chr6

51981375

chr15

30874073

TRA

This study

0.009

0

0

NA

NA

  1. CG copy gain, chr chromosome, DEL deletion, DUP duplication, IED intragenic exon duplication, INV inversion, L-pathogenic Likely pathogenic, MAF minor allele frequency, pLoF potentially loss-of-function, pos position, TRA translocation. Note, all gene names are in italics.
  2. 1Gene impact type based on gene annotation.
  3. 2Population-matched Southern African non-cancer control cohort (n = 49).
  4. 3The ancestry-related MAF in dbVar were based on gnomAD32 or TOPMed42 SV study. The details of all dbVar studies (dbVar study name and ID) and reported allele frequencies were shown in Supplementary Data 1.
  5. 4Presenting at low-frequency rather than rare variants within the ancestrally-defined patient cohort.